Musculoskeletal surgical procedures for patients with bleeding disorders

Location: Atlantico

CE: 1

Chair(s)

Cesar Haddad, MBA

Physiotherapist
Lebanese Association for Hemophilia
Beirut, Lebanon

Co-Chair(s)

Antonio Gavrilovski, PhD (he/him/his)

Orthopaedic Surgeon
University Clinic for Orthopaedic Surgery Skopje
Skopje, Macedonia
Cesar Haddad, MBA

Physiotherapist
Lebanese Association for Hemophilia
Beirut, Lebanon

Speaker(s)

Antonio Gavrilovski, PhD (he/him/his)

Orthopaedic Surgeon
University Clinic for Orthopaedic Surgery Skopje
Skopje, Macedonia
Maria Elisa Mancuso, MD, PhD

Hematologist
IRCCS Humanitas Research Hospital
Milan, Italy
Gianluigi Pasta, MD

Orthopedist
Fondazione IRCCS Policlinico San Matteo Pavia
Milan, Italy

In this session we will explore musculoskeletal surgical procedures from both the orthopedist and hematologist perspective. Topics will include an overview of major surgical interventions available to patients with a bleeding disorder, and how to manage complications post-surgery. We will assess the benefits of using emicizumab for minor musculoskeletal surgical procedures, and evaluate its potential for use in major surgeries, and compare MSK surgeries for patients with and without inhibitors.

Presentations:

11:30 - 11:31 ART

Chair
Co-Chair: Cesar Haddad, MBA – Lebanese Association for Hemophilia
Co-Chair: Antonio Gavrilovski, PhD (he/him/his) – University Clinic for Orthopaedic Surgery Skopje
11:31 - 11:45 ART

Major surgical intervention in Hemophilia
Speaker: Antonio Gavrilovski, PhD (he/him/his) – University Clinic for Orthopaedic Surgery Skopje
11:45 - 12:00 ART

Use of emicizumab for minor surgery
Speaker: Maria Elisa Mancuso, MD, PhD – IRCCS Humanitas Research Hospital
12:00 - 12:15 ART

MSK surgeries for patients with inhibitors
Speaker: Gianluigi Pasta, MD – Fondazione IRCCS Policlinico San Matteo Pavia
12:15 - 12:30 ART

Discussion
Chair: Cesar Haddad, MBA – Lebanese Association for Hemophilia